Abstract

Although several biomarkers are available to monitor the acute phase response, the short pentraxin C-reactive protein (CRP) is dominating in clinical practice. The long pentraxin 3 (PTX3) is structurally and functionally related to CRP, but not liver-derived. In addition, increased levels of PTX3 have been linked to preeclampsia. Reference intervals are usually based on healthy blood donors. Several physiological and immunological alterations occur during normal pregnancy with subsequent potential effects on blood analytes. Hence, this study aims to determine pregnancy-specific reference intervals for CRP and PTX3. Longitudinal clinical data and blood plasma samples from the 1st, 2nd and 3rd trimester of 100 healthy, non-medicating, females aged 18–40 at the time-point of conception were available to us. High‐sensitivity CRP measurements were performed by turbidimetry and enzyme-linked immunosorbent assay (ELISA) was used to quantify PTX3. CRP and PTX3 levels followed each other during the first two trimesters and both increased during the third trimester. CRP showed a median of 4.12 mg/L in the third trimester, and were significantly higher compared to the first (median 2.39 mg/L, p<0.0001) and the second (median 2.44 mg/L, p=0.0006) trimesters. In the third trimester PTX3 levels reached a median of 7.70 µg/L, and were significantly higher compared to the first (median 3.33 µg/L, p<0.0001) and the second (median 3.70 µg/L, p<0.0001) trimesters. Plasma albumin was inversely correlated with CRP (rho=-0.27, p<0.0001), but not with PTX3. In conclusion, it is important to consider pregnancy-specific reference values as elevations of CRP and PTX3 during the later phase may occur in absence of infection.

Highlights

  • C-reactive protein (CRP) belongs to the evolutionary conserved pentraxin family

  • CRP is widely used as a surrogate marker of infection and inflammation in healthcare, specific reference intervals for pregnancies have not been established

  • We included pentraxin 3 (PTX3) as increased levels have been proposed to associate with preeclampsia

Read more

Summary

Introduction

C-reactive protein (CRP) belongs to the evolutionary conserved pentraxin family. It is produced by hepatocytes in response to the inflammatory cytokines, mainly interleukin (IL) -6 and to a minor extent IL-1b, and its blood concentration may increase from less than 1 mg/L to 600–1000 mg/L [1]. This rapid and profound increase makes CRP useful as a marker to monitor inflammatory activity. Circulating CRP levels are used to distinguish bacterial from viral infections [1,2,3]. Since 2010, high sensitivity CRP (hsCRP) detection has been used clinically as a biomarker for prognosis in patients with intermediate risk of cardiovascular disease

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.